Drug Profile
HIV vaccine - GenStar
Alternative Names: LENTI-HIV; MAXIMUM-AD HIVLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator University of California
- Developer Corautus Genetics
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 06 Jun 2007 Corautus Genetics has since been acquired and merged into VIA Pharmaceuticals
- 15 Aug 2003 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
- 16 Jun 2000 Preclinical development for HIV infections treatment in USA (Unspecified route)